Fresenius Medical (FMS) Care will accelerate its share buyback program and start the repurchase of the second tranche. The program – presented during the company’s Capital Markets Day on June 17, 2025 – has a total volume of EUR 1B. Under the second tranche, the company plans to repurchase its own shares for a total amount of around EUR 415M from January 12 to May 8.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical price target raised to $28 from $26 at Truist
- Fresenius Medical price target lowered to EUR 37 from EUR 39 at Morgan Stanley
- Cautious Outlook for Fresenius Medical Care Amid Sector Challenges and Persistent Headwinds
- Fresenius Medical Care Appoints New Global Chief Medical Officer
- Fresenius Medical names Charles Hugh-Jones as Global Chief Medical Officer